Figure 1 (Image 01)
Gabapentin Capsule
Product Images NDC 50090-7673
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
This appears to be a chart showing the results of a study comparing the pain scores of participants taking a placebo versus those taking Gabapentin at different doses over a 4-week period. The study recorded pain scores at baseline and weekly intervals for 7 weeks, with participants receiving either 1800 mg/day or 2400 mg/day of Gabapentin.*
Figure 3 (Image 03)
This is a comparison of the proportion of responders (patients with at least a 50% reduction in pain score) at the endpoint of controlled postherpetic neuralgia (PHN) studies. The chart displays the results of two different studies, showing the percentages for patients on placebo (PBO), gabapentin 3600 mg, gabapentin 1800 mg, and gabapentin 2400 mg. The statistical significance of the results is indicated by the specified p-values.*
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
This text contains information about a daily dose in milligrams. The doses mentioned are 60, 900, 1200, and 1600. The context suggests it may be related to medication or supplement dosage.*
Label Image (Lbl500907673)
This text appears to be a product label. The product is GharsenTIn with 166 MG strength, containing 90 capsules. It is recommended to store it at 8-10 degrees Celsius.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
